Schroders Capital is a leading global private markets investor and part of Schroders Group.

With over USD 70 billion assets under management, the firm manages a range of investment strategies, including private equity, private debt, real estate, infrastructure, securitised products and asset-based finance, insurance-linked securities and impact investing on behalf of institutions, consultants, family offices and individual investors. Schroders Capital operates out of 19 offices globally and employs over 500 professionals, combining global market coverage with local, on-the-ground presence.

In 2022, Schroder Capital invested in Domain Therapeutics to support the progression of the company toward clinical stage.